{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:06:11Z","timestamp":1783933571422,"version":"3.55.0"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":125,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.prdoa.2026.100452","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:15:35Z","timestamp":1778368535000},"page":"100452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sexual dysfunction in movement disorders: prevalence, clinical features, associated factors and management"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6534-8819","authenticated-orcid":false,"given":"Vincent","family":"Leclercq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prdoa.2026.100452_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101665","article-title":"The association between Parkinson\u2019s disease and sexual dysfunction: clinical correlation and therapeutic implications","volume":"79","author":"Ng","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1474-4422(22)00036-9","article-title":"Approach and management to patients with neurological disorders reporting sexual dysfunction","volume":"21","author":"Hentzen","year":"2022","journal-title":"The Lancet Neurol."},{"issue":"10","key":"10.1016\/j.prdoa.2026.100452_b0015","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jsxm.2020.06.010","article-title":"Sexual dysfunction in Parkinson disease: a multicenter Italian cross-sectional study on a still overlooked problem","volume":"17","author":"Raciti","year":"2020","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.prdoa.2026.100452_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1083864","article-title":"Discussing sexuality with patients with neurological diseases: a survey among neurologists working in Saudi Arabia","volume":"14","author":"Almalki","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12883-022-02884-y","article-title":"Assessment of sexual dysfunction in patients with multiple sclerosis: a perspective from neurologist","volume":"22","author":"Gaviria- Carrillo","year":"2022","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.prdoa.2026.100452_b0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00702-019-02053-5","article-title":"Discussing sexuality with Parkinson\u2019s disease patients: a multinational survey among neurologists","volume":"126","author":"De Rooy","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.prdoa.2026.100452_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2023.09.008","article-title":"Sexual dysfunction among patients with Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"117","author":"Vafaeimastanabad","year":"2023","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm14010152","article-title":"Determinants of sexual dysfunction in Parkinson\u2019s disease patients: a secondary analysis of a multicenter cross-sectional study","volume":"14","author":"Manuli","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.prdoa.2026.100452_b0045","doi-asserted-by":"crossref","unstructured":"Buhmann C. Chapter One - Prevalence, clinical presentations and impact on relationship of sexual dysfunction in Parkinson\u2019s Disease. In: Chaudhuri KR, Falup-Pecurariu C, Parry M, editors International Review of Neurobiology. Academic Press;p1\u20131https:\/\/doi.org\/10.1016\/bs.irn.2021.12.001.","DOI":"10.1016\/bs.irn.2021.12.001"},{"key":"10.1016\/j.prdoa.2026.100452_b0050","doi-asserted-by":"crossref","unstructured":"Batzu L, Titova N, Bhattacharyya KB, Chaudhuri KR. Chapter Two - The pathophysiology of sexual dysfunction in Parkinson\u2019s disease: An overview. In: Chaudhuri KR, Falup-Pecurariu C, Parry M, editors International Review of Neurobiology. Academic Press;p21\u201334. https:\/\/doi.org\/10.1016\/bs.irn.2022.01.001.","DOI":"10.1016\/bs.irn.2022.01.001"},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update","volume":"16","author":"Voon","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson\u2019s disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","article-title":"Risk factors for non-motor symptoms in Parkinson\u2019s disease","volume":"17","author":"Marinus","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/jnp.6.2.147","article-title":"Sexual disorders in Huntington\u2019s disease","volume":"6","author":"Fedoroff","year":"1994","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.prdoa.2026.100452_b0080","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jns.2015.11.015","article-title":"Male sexual function in presymptomatic gene carriers and patients with Huntington\u2019s disease","volume":"359","author":"Kolenc","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.prdoa.2026.100452_b0085","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2147\/NDT.S175193","article-title":"Sexual dysfunction in cervical dystonia and blepharospasm","volume":"14","author":"Marek","year":"2018","journal-title":"NDT"},{"key":"10.1016\/j.prdoa.2026.100452_b0090","doi-asserted-by":"crossref","unstructured":"Perozzo P, Salatino A, Cerrato P, Ricci R. Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study. Front Psychol;7. https:\/\/doi.org\/10.3389\/fpsyg.2016.01492.","DOI":"10.3389\/fpsyg.2016.01492"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jsxm.2018.12.017","article-title":"Parkinson\u2019s disease is associated with risk of sexual dysfunction in men but not in women: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2019","journal-title":"J. Sex. Med."},{"issue":"7","key":"10.1016\/j.prdoa.2026.100452_b0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40263-017-0450-z","article-title":"Dopaminergic therapies for non-motor symptoms in Parkinson\u2019s disease","volume":"31","author":"Schaeffer","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.prdoa.2026.100452_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.irn.2021.12.008","article-title":"Chapter six - Impulse control disorders, dopamine dysregulation syndrome and sex dysfunction in Parkinson\u2019s disease","volume":"162","author":"Irincu","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.prdoa.2026.100452_b0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuroscience.2025.05.030","article-title":"Resting-state fMRI study on male patients with Parkinson\u2019s disease and with sexual dysfunction","volume":"577","author":"Qin","year":"2025","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.22519","article-title":"Genitourinary dysfunction in Parkinson\u2019s disease","volume":"25","author":"Sakakibara","year":"2010","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0120","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1743-6109.2010.02190.x","article-title":"The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature","volume":"8","author":"Moll","year":"2011","journal-title":"J. Sex. Med."},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0125","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/mds.28722","article-title":"Serotonergic and dopaminergic lesions underlying Parkinsonian neuropsychiatric signs","volume":"36","author":"Maillet","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2026.100452_b0130","doi-asserted-by":"crossref","unstructured":"Varl\u0131ba\u015f H, Erdo\u011fan HA, Acir I, Yayla V. Relationship between autonomic dysfunction and sexual dysfunctions in Parkinson\u2019s patients. Frontiers in Aging Neuroscience;17. https:\/\/doi.org\/10.3389\/fnagi.2025.1562003.","DOI":"10.3389\/fnagi.2025.1562003"},{"key":"10.1016\/j.prdoa.2026.100452_b0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autneu.2017.01.005","article-title":"The neurologic control of arousal and orgasm with specific attention to spinal cord lesions: Integrating preclinical and clinical sciences","volume":"209","author":"Alexander","year":"2018","journal-title":"Auton. Neurosci."},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S1474-4422(24)00396-X","article-title":"Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment","volume":"23","author":"Krismer","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0145","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2488111","article-title":"Autonomic dysfunction in multiple system atrophy: from pathophysiology to clinical manifestations","volume":"57","author":"Luo","year":"2025","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.27186","article-title":"Neuropathology of autonomic dysfunction in synucleinopathies","volume":"33","author":"Coon","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2026.100452_b0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fneur.2019.00363","article-title":"Autonomic Dysfunction in \u03b1-Synucleinopathies","volume":"10","author":"Mendoza-Vel\u00e1squez","year":"2019","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41443-022-00656-3","article-title":"Understanding the dopaminergic pathway relative to men\u2019s sexual dysfunction in patients with Parkinson\u2019s disease: a narrative review with implications for future research","volume":"36","author":"Deebel","year":"2024","journal-title":"Int. J. Impot. Res."},{"issue":"9861","key":"10.1016\/j.prdoa.2026.100452_b0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(12)60520-0","article-title":"Erectile dysfunction","volume":"381","author":"Shamloul","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.prdoa.2026.100452_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2026.01.001","article-title":"Cytokine associated neuroinflammation in Parkinson\u2019s disease: molecular pathways, therapeutic targets, and translational insights","volume":"88","author":"Dhapola","year":"2026","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.prdoa.2026.100452_b0175","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson\u2019s disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.prdoa.2026.100452_b0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pneurobio.2012.06.005","article-title":"Emerging roles of microglial activation and non-motor symptoms in Parkinson\u2019s disease","volume":"98","author":"Doorn","year":"2012","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","article-title":"Initiation of pharmacological therapy in Parkinson\u2019s disease: when, why, and how","volume":"19","author":"De Bie","year":"2020","journal-title":"The Lancet Neurol."},{"key":"10.1016\/j.prdoa.2026.100452_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.108147","article-title":"Impulse control disorders and dopamine receptor agonism in Parkinson\u2019s disease patients: clinical implications","volume":"143","author":"Tangedal","year":"2026","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0200","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/01616412.2024.2407645","article-title":"Effect of deep brain stimulation on sexual dysfunction among patients who had Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"46","author":"Bahadori","year":"2024","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/NRL.0000000000000272","article-title":"The impact of deep brain stimulation on the sexual function of patients with Parkinson\u2019s disease","volume":"25","author":"Pedro","year":"2020","journal-title":"Neurologist"},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ane.13652","article-title":"Effects of subthalamic deep brain stimulation on non\u2010motor symptoms of Parkinson\u2019s disease: a meta\u2010analysis","volume":"146","author":"Eghlidos","year":"2022","journal-title":"Acta Neuro Scandinavica"},{"key":"10.1016\/j.prdoa.2026.100452_b0215","doi-asserted-by":"crossref","unstructured":"Castelli L, Perozzo P, Genesia M, et al. Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Journal of Neurology Neurosurgery & Psychiatry. https:\/\/doi.org\/10.1136\/jnnp.2003.034579.","DOI":"10.1136\/jnnp.2003.034579"},{"key":"10.1016\/j.prdoa.2026.100452_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1397344","article-title":"Impact of deep brain stimulation on urogenital function in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Neurol."},{"issue":"24","key":"10.1016\/j.prdoa.2026.100452_b0225","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.4103\/0366-6999.171464","article-title":"Target selection recommendations based on impact of deep brain stimulation surgeries on nonmotor symptoms of Parkinson\u2019s disease","volume":"128","author":"Wang","year":"2015","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"10","key":"10.1016\/j.prdoa.2026.100452_b0230","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neurol.2024.07.001","article-title":"Impulse control disorder: review on clinical, pharmacologic, and genetic risk factors","volume":"180","author":"Leclercq","year":"2024","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12883-015-0316-2","article-title":"DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients","volume":"15","author":"Zainal Abidin","year":"2015","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ene.14590","article-title":"Integrating genetic and clinical data to predict impulse control disorders in Parkinson\u2019s disease","volume":"28","author":"Jes\u00fas","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0245","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","article-title":"Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson\u2019s disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0250","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/08919887211063810","article-title":"Sexual dysfunction among Egyptian idiopathic Parkinson\u2019s disease patients","volume":"35","author":"Elshamy","year":"2021","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"8","key":"10.1016\/j.prdoa.2026.100452_b0255","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s10072-020-04328-2","article-title":"Sexual dysfunction in male patients with Parkinson\u2019s disease: related factors and impact on quality of life","volume":"41","author":"Shalash","year":"2020","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0260","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3233\/JPD-202066","article-title":"Sexual dysfunction in early-onset Parkinson\u2019s disease: a cross-sectional multicenter study","volume":"10","author":"Vela-Desojo","year":"2020","journal-title":"J. Parkinson\u2019s Disease"},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/brainsci12020159","article-title":"Sexual dysfunctions in Parkinson\u2019s disease and their influence on partnership\u2014data of the PRISM Study","volume":"12","author":"Kinateder","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.prdoa.2026.100452_b0270","unstructured":"Zhu J, Shen B, Pan Y. Prevalence and risk factors of sexual dysfunction in patients with Parkinson\u2019s disease. https:\/\/doi.org\/10.3760\/CMA.J.ISSN.0254-9026.2016.01.008."},{"key":"10.1016\/j.prdoa.2026.100452_b0275","doi-asserted-by":"crossref","unstructured":"Jitkritsadakul O, Jagota P, Bhidayasiri R. Postural instability, the absence of sexual intercourse in the past month, and loss of libido are predictors of sexual dysfunction in Parkinson\u2019s disease. Parkinsonism & Related Disorders. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.11.003.","DOI":"10.1016\/j.parkreldis.2014.11.003"},{"key":"10.1016\/j.prdoa.2026.100452_b0280","doi-asserted-by":"crossref","unstructured":"Kaya Y, Ozer F, Benli E, et al. Evaluation of sexual dysfunction in Parkinson\u2019s disease between two different regions of Turkey. Clinical neurology and neurosurgery (Dutch-Flemish ed Print). https:\/\/doi.org\/10.1016\/j.clineuro.2017.08.014.","DOI":"10.1016\/j.clineuro.2017.08.014"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3928\/02793695-20220907-02","article-title":"Sexual dysfunction and related factors in patients with Parkinson\u2019s disease","volume":"61","author":"Haktan\u0131r","year":"2023","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"issue":"S1","key":"10.1016\/j.prdoa.2026.100452_b0290","doi-asserted-by":"crossref","first-page":"S1095","DOI":"10.1192\/j.eurpsy.2023.2327","article-title":"Sexual dysfunction and motor disability in Parkinson\u2019s disease: any link?","volume":"66","author":"Mousli","year":"2023","journal-title":"Eur. Psychiatr."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0295","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s13760-022-02086-w","article-title":"Discussing sexual health among Flemish patients with Parkinson\u2019s disease","volume":"123","author":"Van Overmeire","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0300","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1743-6109.2008.01083.x","article-title":"Loss of Libido in Parkinson\u2019s Disease","volume":"6","author":"Kummer","year":"2009","journal-title":"J. Sex. Med."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0305","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/136140968900300405","article-title":"Sexual dysfunction in men with Parkinson\u2019s disease","volume":"3","author":"Singer","year":"1989","journal-title":"Neurorehabil. Neural Repair"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0310","first-page":"11","article-title":"Autonomic disorders in Parkinson\u2019s disease","volume":"57","author":"Go\u0142ab-Janowska","year":"2011","journal-title":"Ann. Acad. Med. Stetin."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0315","first-page":"518","article-title":"Male sexual dysfunction and Parkinson\u2019s disease: a preliminary investigation. Zhonghua nan ke xue=","volume":"19","author":"Hu","year":"2013","journal-title":"Natl. J. Androl."},{"key":"10.1016\/j.prdoa.2026.100452_b0320","doi-asserted-by":"crossref","unstructured":"Panichelli B arbara S, Rosa-Campos F, Chaves F avia S, et al. Sexual dysfunction in Parkinson\u2019s disease: what about women? Journal of Neurological Sciences. https:\/\/doi.org\/10.1016\/j.jns.2026.125757.","DOI":"10.1016\/j.jns.2026.125757"},{"key":"10.1016\/j.prdoa.2026.100452_b0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2016.07.058","article-title":"Abnormal sexuality in Parkinson\u2019s disease: fact or fancy?","volume":"369","author":"Ferrucci","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0330","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00926230490258893","article-title":"Sexual dysfunction in Parkinson\u2019s disease","volume":"30","author":"Bronner","year":"2004","journal-title":"J. Sex Marital Ther."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0335","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00702-023-02729-z","article-title":"Sexual dysfunction in men with young onset Parkinson\u2019s disease","volume":"131","author":"Sandeep","year":"2024","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0340","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41443-018-0034-6","article-title":"Acquired premature ejaculation in Parkinson\u2019s disease and possible mechanisms","volume":"30","author":"Bronner","year":"2018","journal-title":"Int J Impot Res"},{"issue":"1\u20132","key":"10.1016\/j.prdoa.2026.100452_b0345","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00295-8","article-title":"Questionnaire-based assessment of pelvic organ dysfunction in Parkinson\u2019s disease","volume":"92","author":"Sakakibara","year":"2001","journal-title":"Auton. Neurosci."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0350","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/medicina59050845","article-title":"Sexual dysfunctions in females with Parkinson\u2019s disease: a cross-sectional study with a psycho-endocrinological perspective","volume":"59","author":"De Luca","year":"2023","journal-title":"Medicina"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0355","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10072-023-07091-2","article-title":"Sexual dysfunction in a sample of Egyptian patients with Parkinson\u2019s disease","volume":"45","author":"Deraz","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.prdoa.2026.100452_b0360","doi-asserted-by":"crossref","unstructured":"Yu M, Roane D, Miner C, Fleming MP, Rogers JD. Dimensions of sexual dysfunction in Parkinson disease. The American journal of geriatric psychiatry. https:\/\/doi.org\/10.1097\/00019442-200403000-00013.","DOI":"10.1097\/00019442-200403000-00013"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0365","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.purol.2010.05.006","article-title":"\u00c9valuation par l\u2019index international de la fonction \u00e9rectile (IIEF-15) de la fonction sexuelle des hommes atteints d\u2019une maladie de Parkinson idiopathique","volume":"21","author":"Roumigui\u00e9","year":"2011","journal-title":"Progr\u00e8s En Urologie"},{"issue":"117","key":"10.1016\/j.prdoa.2026.100452_b0370","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.npg.2020.01.003","article-title":"\u00c9valuation de la sexualit\u00e9 des hommes parkinsoniens","volume":"20","author":"Boulma","year":"2020","journal-title":"NPG Neurologie-Psychiatrie-G\u00e9riatrie"},{"key":"10.1016\/j.prdoa.2026.100452_b0375","doi-asserted-by":"crossref","unstructured":"Nasimbera A, Rosales J, Silva B, et al. Everything you always wanted to know about sex and Neurology: neurological disability and sexuality. Arquivos de Neuro-Psiquiatria. https:\/\/doi.org\/10.1590\/0004-282X20180061.","DOI":"10.1590\/0004-282x20180061"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0380","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic","year":"2012","journal-title":"The Lancet Neurol."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-System Atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0390","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update","volume":"8","author":"Stefanova","year":"2009","journal-title":"The Lancet Neurol."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0395","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10286-021-00825-2","article-title":"Female sexual dysfunction in multiple system atrophy: a prospective cohort study","volume":"31","author":"Raccagni","year":"2021","journal-title":"Clin. Auton. Res."},{"issue":"9","key":"10.1016\/j.prdoa.2026.100452_b0400","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1007\/s00415-023-11807-x","article-title":"Neurological update: non-motor symptoms in atypical parkinsonian syndromes","volume":"270","author":"Ananthavarathan","year":"2023","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jnnp-2018-319374","article-title":"Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy","volume":"90","author":"Oliveira","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41531-017-0037-x","article-title":"Non motor symptoms in progressive supranuclear palsy: prevalence and severity","volume":"3","author":"Radicati","year":"2017","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"10.1016\/j.prdoa.2026.100452_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1081219","article-title":"Non-motor symptoms in multiple system atrophy: a comparative study with Parkinson\u2019s disease and progressive supranuclear palsy","volume":"13","author":"Hu","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.prdoa.2026.100452_b0420","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.parkreldis.2015.08.034","article-title":"Non-motor symptoms in essential tremor: a review of the current data and state of the field","volume":"22","author":"Louis","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2011.12.003","article-title":"Essential tremor: beyond the motor features","volume":"18","author":"Chandran","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.prdoa.2026.100452_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.891446","article-title":"Essential tremor patients experience significant burden beyond tremor: a systematic literature review","volume":"13","author":"Gerbasi","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245918","article-title":"Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson\u2019s disease","volume":"16","author":"Shalash","year":"2021","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.prdoa.2026.100452_b0440","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMcp1707928","article-title":"Essential Tremor","volume":"378","author":"Haubenberger","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prdoa.2026.100452_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120336","article-title":"Differences in clinical manifestations of late-onset, compared to earlier-onset essential tremor: a scoping review","volume":"440","author":"Wang","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.prdoa.2026.100452_b0450","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000492831","article-title":"The roles of age and aging in essential tremor: an epidemiological perspective","volume":"52","author":"Louis","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0455","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5603\/JNNS.a2020.0025","article-title":"Sexual dysfunction in Huntington\u2019s Disease\u2014A systematic review","volume":"54","author":"Szymu\u015b","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0460","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JHD-160224","article-title":"Female sexual dysfunction in presymptomatic mutation carriers and patients with Huntington\u2019s disease","volume":"6","author":"Kolenc","year":"2017","journal-title":"Journal of Huntington\u2019s Disease"},{"key":"10.1016\/j.prdoa.2026.100452_b0465","doi-asserted-by":"crossref","unstructured":"Teive H, Moro A, Moscovich M, Munhoz R. Increased sexual arousal in patients with movement disorders. Arquivos de Neuro-Psiquiatria. https:\/\/doi.org\/10.1590\/0004-282X20150217.","DOI":"10.1590\/0004-282X20150217"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0470","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/brain\/awac440","article-title":"Reproductive characteristics, use of exogenous hormones and Parkinson disease in women from the E3N study","volume":"146","author":"Pesce","year":"2023","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0475","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1007\/s00415-024-12258-8","article-title":"A biological characterization of patients with postmenopausal Parkinson\u2019s disease","volume":"271","author":"Bovenzi","year":"2024","journal-title":"J. Neurol."},{"issue":"9561","key":"10.1016\/j.prdoa.2026.100452_b0480","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)60280-3","article-title":"Sexual dysfunction in men and women with endocrine disorders","volume":"369","author":"Bhasin","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.prdoa.2026.100452_b0485","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.irn.2021.12.002","article-title":"Scales and assessments of sexual dysfunction","volume":"162","author":"Rodriguez-Blazquez","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"issue":"11","key":"10.1016\/j.prdoa.2026.100452_b0490","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/mds.26739","article-title":"Sexual dysfunction in women with Parkinson\u2019s disease","volume":"31","author":"Varanda","year":"2016","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0495","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10072-022-06467-0","article-title":"Sexual needs and sexual function of patients with Parkinson\u2019s disease","volume":"44","author":"Bronner","year":"2023","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0500","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp.53.6.480","article-title":"Sexual function in patients with Parkinson\u2019s disease and their partners","volume":"53","author":"Brown","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.prdoa.2026.100452_b0505","doi-asserted-by":"crossref","unstructured":"Bronner G, Cohen O, Yahalom G, et al. Correlates of quality of sexual life in male and female patients with Parkinson disease and their partners. Parkinsonism & Related Disorders. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.07.003.","DOI":"10.1016\/j.parkreldis.2014.07.003"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0510","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/neu.2014.33","article-title":"The relation of sexual dysfunction to depression and anxiety in patients with Parkinson\u2019s disease","volume":"27","author":"\u00d6zcan","year":"2015","journal-title":"Acta Neuropsychiatrica"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0515","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10286-016-0356-8","article-title":"The association between symptoms of sexual dysfunction and age at onset in Parkinson\u2019s disease","volume":"26","author":"\u00d6zcan","year":"2016","journal-title":"Clin. Auton. Res."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0520","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JPD-230212","article-title":"The impact of motor, non-motor, and social aspects on the sexual health of men living with Parkinson\u2019s disease","volume":"14","author":"Souza","year":"2024","journal-title":"J. Parkinson\u2019s Disease"},{"key":"10.1016\/j.prdoa.2026.100452_b0525","doi-asserted-by":"crossref","unstructured":"Deng X, Xiao B, Li H, et al. Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson\u2019s disease. Journal of Neurology. https:\/\/doi.org\/10.1007\/s00415-015-7855-8.","DOI":"10.1007\/s00415-015-7855-8"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0530","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clineuro.2012.06.020","article-title":"Psychiatric factors related to sexual functioning in patients with Parkinson\u2019s disease","volume":"115","author":"Kotkov\u00e1","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0535","first-page":"28","article-title":"Determinants of sexual dysfunction in male and female patients with Parkinson\u2019s disease","volume":"26","author":"Atag\u00fcn","year":"2013","journal-title":"Dusunen Adam J. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.prdoa.2026.100452_b0540","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.02.017","article-title":"The prevalence and clinical characteristics of hypersexuality in patients with Parkinson\u2019s disease following dopaminergic therapy: a systematic literature review","volume":"25","author":"Nakum","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0545","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.nrleng.2015.05.008","article-title":"Clinical and psychopathological factors associated with impulse control disorders in Parkinson\u2019s disease","volume":"31","author":"S\u00e1ez-Franc\u00e0s","year":"2016","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0550","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0555","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00002826-199704000-00005","article-title":"Psychiatric and sexual disorders induced by apomorphine in Parkinson\u2019s disease","volume":"20","author":"Courty","year":"1997","journal-title":"Clin. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.prdoa.2026.100452_b0560","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(09)70183-8","article-title":"Treatment of hyperkinetic movement disorders","volume":"8","author":"Jankovic","year":"2009","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0565","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","article-title":"Treatment of patients with essential tremor","volume":"10","author":"Deuschl","year":"2011","journal-title":"The Lancet Neurol."},{"key":"10.1016\/j.prdoa.2026.100452_b0570","doi-asserted-by":"crossref","unstructured":"Katzenschlager R, Sampaio C, Costa J, Lees A. Anticholinergics for symptomatic management of Parkinso\u0144s disease. Cochrane Database of Systematic Reviews;(3). https:\/\/doi.org\/10.1002\/14651858.CD003735.","DOI":"10.1002\/14651858.CD003735"},{"issue":"7","key":"10.1016\/j.prdoa.2026.100452_b0575","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5694\/mja2.50522","article-title":"Antidepressant\u2010induced sexual dysfunction","volume":"212","author":"Rothmore","year":"2020","journal-title":"Med. J. Aust."},{"issue":"8","key":"10.1016\/j.prdoa.2026.100452_b0580","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jsxm.2021.05.016","article-title":"Erectile and ejaculatory dysfunction associated with use of psychotropic drugs: a systematic review","volume":"18","author":"Trinchieri","year":"2021","journal-title":"J. Sex. Med."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0585","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40264-025-01631-9","article-title":"Sexual dysfunction in male patients after initiating treatment with antidepressants","volume":"49","author":"Westphal","year":"2026","journal-title":"Drug Saf."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0590","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(18)30495-2","article-title":"Management of epilepsy in women","volume":"18","author":"Stephen","year":"2019","journal-title":"The Lancet Neurology"},{"issue":"9560","key":"10.1016\/j.prdoa.2026.100452_b0595","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(07)60238-4","article-title":"Sexual function in men and women with neurological disorders","volume":"369","author":"Rees","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.prdoa.2026.100452_b0600","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/14740338.2016.1112376","article-title":"Sexual dysfunction related to antiepileptic drugs in patients with epilepsy","volume":"15","author":"Yang","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.prdoa.2026.100452_b0610","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2017.05.014","article-title":"Topiramate-associated sexual dysfunction: a systematic review","volume":"73","author":"Chen","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"37","key":"10.1016\/j.prdoa.2026.100452_b0615","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.2174\/1381612823666171004115230","article-title":"Sexual dysfunction in epilepsy and the role of anti-epileptic drugs","volume":"23","author":"Yogarajah","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"10503","key":"10.1016\/j.prdoa.2026.100452_b0620","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(25)01072-4","article-title":"Vesicular monoamine transport inhibitors: current uses and future directions","volume":"406","author":"Rosenthal","year":"2025","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.prdoa.2026.100452_b0625","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s40265-017-0831-0","article-title":"Deutetrabenazine: a review in chorea associated with Huntington\u2019s disease","volume":"77","author":"Heo","year":"2017","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.prdoa.2026.100452_b0630","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40263-022-00956-8","article-title":"The safety of deutetrabenazine for chorea in huntington disease: an open-label extension study","volume":"36","author":"Frank","year":"2022","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.prdoa.2026.100452_b0635","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1474-4422(16)00132-0","article-title":"Advances in management of movement disorders in children","volume":"15","author":"Koy","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.13189\/ijnbs.2014.020101","article-title":"Parkinson\u2019s disease and sexual dysfunctions in men","volume":"2","author":"Nabi","year":"2014","journal-title":"Int. J. Neurosci. Behav. Sci."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0645","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.59.5.807","article-title":"Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity","volume":"59","author":"Okun","year":"2002","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.prdoa.2026.100452_b0650","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S2213-8587(18)30026-3","article-title":"The physiology of endocrine systems with ageing","volume":"6","author":"Van Den Beld","year":"2018","journal-title":"The Lancet Diab. Endocrinol."},{"issue":"7","key":"10.1016\/j.prdoa.2026.100452_b0655","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/ene.15801","article-title":"Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study","volume":"30","author":"Bovenzi","year":"2023","journal-title":"Euro J. Neurol."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0660","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ane.12334","article-title":"Prolactin and sex hormones levels in males with Parkinson\u2019s disease","volume":"131","author":"Nitkowska","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.prdoa.2026.100452_b0665","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yfrne.2017.09.002","article-title":"Sex differences in Parkinson\u2019s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics","volume":"50","author":"Jurado-Coronel","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.prdoa.2026.100452_b0670","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2014.03.010","article-title":"Sex differences in Parkinson\u2019s disease and other movement disorders","volume":"259","author":"Smith","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0675","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1038\/s41598-019-47026-6","article-title":"Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-na\u00efve postmenopausal Parkinson\u2019s disease","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.prdoa.2026.100452_b0680","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson\u2019s disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"The Lancet Neurol."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0685","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/brain\/awaf087","article-title":"Serotonergic dysfunction in patients with impulse control disorders in Parkinson\u2019s disease","volume":"148","author":"Prange","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.prdoa.2026.100452_b0690","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2026.1768251","article-title":"Neuropsychological aspects of impulse control disorders in Parkinson\u2019s disease","volume":"18","author":"Scanferla","year":"2026","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.prdoa.2026.100452_b0695","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.02.018","article-title":"The relationship between Impulse Control Disorders and cognitive dysfunctions in Parkinson\u2019s Disease: a meta-analysis","volume":"77","author":"Santangelo","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0700","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mdc3.12155","article-title":"Hypersexuality in Parkinson\u2019s disease: systematic review and report of 7 new cases","volume":"2","author":"Codling","year":"2015","journal-title":"Movement Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0705","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-300998","article-title":"Hypersexuality in neurological disorders: a systematic review","volume":"27","author":"Tayim","year":"2024","journal-title":"BMJ Ment. Health"},{"key":"10.1016\/j.prdoa.2026.100452_b0710","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/IJGM.S4674","article-title":"Prevalence of hypersexual behavior in Parkinson\u2019s disease patients: not restricted to males and dopamine agonist use","author":"Cooper","year":"2009","journal-title":"Int. J. General Med."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0715","doi-asserted-by":"crossref","first-page":"28697","DOI":"10.1038\/s41598-024-79966-z","article-title":"A qualitative study exploring the clinical phenomenology and impact of hypersexuality in patients with Parkinson\u2019s Disease","volume":"14","author":"Tayim","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prdoa.2026.100452_b0720","doi-asserted-by":"crossref","unstructured":"Grandgenevre P, Warembourg F, Carri\u00e8re N, et al. Prise en charge de l\u2019hypersexualit\u00e9 dans la maladie de Parkinson. Int\u00e9r\u00eat de la pr\u00e9sence de l\u2019entourage lors de l\u2019\u00e9valuation m\u00e9dicale. La Presse M\u00e9dicale 2015;44(3):e51\u2013e58.","DOI":"10.1016\/j.lpm.2014.06.037"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0725","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090870","article-title":"Impact of hypersexuality on spousal carers of patients with Parkinson\u2019s disease and frontotemporal dementia: a qualitative study","volume":"15","author":"Tayim","year":"2025","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0730","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.27689","article-title":"Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: critique and recommendations","volume":"34","author":"Evans","year":"2019","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0735","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JPD-2012-012098","article-title":"Exploring hypersexual behavior in men with Parkinson\u2019s disease: is it compulsive sexual behavior?","volume":"2","author":"Bronner","year":"2012","journal-title":"J. Parkinson\u2019s Disease"},{"key":"10.1016\/j.prdoa.2026.100452_b0740","doi-asserted-by":"crossref","unstructured":"Young K, McDonell KE, Claassen D. Behavioral Variant Frontotemporal Degeneration or Parkinson\u2019s Disease? Not All Hypersexuality Is Impulse Control Disorder (P6.387). Neurology. https:\/\/doi.org\/10.1212\/wnl.86.16_supplement.p6.387.","DOI":"10.1212\/WNL.86.16_supplement.P6.387"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0745","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/pcn.13523","article-title":"A circuit\u2010based approach to modulate hypersexuality in Parkinson\u2019s disease","volume":"77","author":"Mata-Mar\u00edn","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0750","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1756285611411504","article-title":"Management of sexual dysfunction in Parkinson\u2019s disease","volume":"4","author":"Bronner","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0755","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mdc3.12456","article-title":"Sildenafil in the treatment of erectile dysfunction in Parkinson\u2019s disease","volume":"4","author":"Bernard","year":"2017","journal-title":"Movement Disord. Clin. Pract."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0760","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson\u2019s disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0765","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/CPJ.0b013e318278be9b","article-title":"Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease","volume":"2","author":"Weiss","year":"2012","journal-title":"Neur. Clin. Pract."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0770","doi-asserted-by":"crossref","first-page":"32","DOI":"10.52818\/cjmrtu.2021.8","article-title":"Hypersexuality complication of dopamine agonists: pramipexole or ropinirole","volume":"1","author":"Arici","year":"2021","journal-title":"Cjmrtu"},{"issue":"02","key":"10.1016\/j.prdoa.2026.100452_b0775","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0037-1601887","article-title":"Impulse control disorders and related complications of Parkinson\u2019s disease therapy","volume":"37","author":"Lopez","year":"2017","journal-title":"Semin. Neurol."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0780","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/0028-3886.44830","article-title":"Hypersexuality following subthalamic nucleus stimulation for Parkinson\u2019s disease","volume":"56","author":"Doshi","year":"2008","journal-title":"Neurol. India"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0785","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.20br02663","article-title":"Treatment of pramipexole-induced problematic sexual behaviors","volume":"23","author":"Murphy","year":"2021","journal-title":"The Primary Care Companion for CNS Disorders"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0790","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.brs.2020.09.019","article-title":"Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson\u2019s disease","volume":"13","author":"Dafsari","year":"2020","journal-title":"Brain Stimul."},{"key":"10.1016\/j.prdoa.2026.100452_b0795","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fneur.2019.00086","article-title":"Medications, deep brain stimulation, and other factors influencing impulse control disorders in Parkinson\u2019s disease","volume":"10","author":"Eisinger","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0800","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00415-016-8314-x","article-title":"Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease","volume":"264","author":"Merola","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.prdoa.2026.100452_b0805","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fneur.2019.00617","article-title":"Mood effects after deep brain stimulation for Parkinson\u2019s disease: an update","volume":"10","author":"Accolla","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.prdoa.2026.100452_b0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/759895","article-title":"Dopamine dysregulation syndrome and deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease","volume":"2011","author":"De La Casa-Fages","year":"2011","journal-title":"Neurol. Res. Int."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0815","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.prdoa.2026.100452_b0820","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1474-4422(09)70225-X","article-title":"A reassessment of risks and benefits of dopamine agonists in Parkinson\u2019s disease","volume":"8","author":"Antonini","year":"2009","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1016\/j.prdoa.2026.100452_b0825","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00023210-200721080-00005","article-title":"Medical management of levodopa-associated motor complications in patients with Parkinson\u2019s disease","volume":"21","author":"Jankovic","year":"2007","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.prdoa.2026.100452_b0830","first-page":"679","article-title":"Parkinson disease","volume":"102","author":"Halli-Tierney","year":"2020","journal-title":"Am. Fam. Physician"},{"issue":"8","key":"10.1016\/j.prdoa.2026.100452_b0835","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(23)00068-6","article-title":"Autosomal dominant cerebellar ataxias: new genes and progress towards treatments","volume":"22","author":"Coarelli","year":"2023","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0840","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/YCO.0000000000000198","article-title":"Sexual side-effects of antidepressant and antipsychotic drugs","volume":"28","author":"Montejo","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0845","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/wps.20509","article-title":"The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management","volume":"17","author":"Montejo","year":"2018","journal-title":"World Psychiatry"},{"issue":"10423","key":"10.1016\/j.prdoa.2026.100452_b0850","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson\u2019s disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.prdoa.2026.100452_b0855","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1007\/s10072-022-06188-4","article-title":"Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson\u2019s disease and sleep disorders: a randomized, double-blind trial","volume":"43","author":"Hadi","year":"2022","journal-title":"Neurol. Sci."},{"issue":"16","key":"10.1016\/j.prdoa.2026.100452_b0860","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1080\/14656566.2024.2422004","article-title":"Pharmacological and non-pharmacological management of sleep disturbances in Parkinson\u2019s disease: if when and how","volume":"25","author":"Falup-Pecurariu","year":"2024","journal-title":"Expert Opin. Pharmacother."},{"issue":"11","key":"10.1016\/j.prdoa.2026.100452_b0865","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamapsychiatry.2023.2696","article-title":"Sexual dysfunction in schizophrenia: a systematic review and meta-analysis","volume":"80","author":"Korchia","year":"2023","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.prdoa.2026.100452_b0870","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4530(02)00113-0","article-title":"Sexual dysfunction and antipsychotic treatment","volume":"28","author":"Cutler","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0875","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings","volume":"41","author":"De Boer","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"01","key":"10.1016\/j.prdoa.2026.100452_b0880","first-page":"1","article-title":"Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs","volume":"47","author":"La Torre","year":"2014","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"10.1016\/j.prdoa.2026.100452_b0885","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","article-title":"Sleep and sleep disorders in people with Parkinson\u2019s disease","volume":"23","author":"Iranzo","year":"2024","journal-title":"The Lancet Neurology"},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0890","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/mds.27860","article-title":"Deep brain stimulation in movement disorders: from experimental surgery to evidence\u2010based therapy","volume":"34","author":"Krack","year":"2019","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100452_b0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294240","article-title":"Dealing with the diagnosis of Parkinson\u2019s disease and its implications for couple functioning in the early stage: an interpretative phenomenological analysis","volume":"19","author":"Wawrziczny","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0900","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00737-020-01080-6","article-title":"The effect of counseling based on the PLISSIT model on sexual quality of life of married women with multiple sclerosis referring to MS center in 2019: a randomized, controlled trial","volume":"24","author":"Kazemi","year":"2021","journal-title":"Arch. Womens Ment. Health"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0905","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1474-4422(25)00305-9","article-title":"The role of lifestyle interventions in symptom management and disease modification in Parkinson\u2019s disease","volume":"25","author":"Trinh","year":"2026","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.prdoa.2026.100452_b0910","article-title":"Interventions for sexual dysfunction following stroke","volume":"5","author":"Stratton","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0915","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neurom.2024.02.004","article-title":"Short-term dorsal genital nerve stimulation increases subjective arousal in women with and without spinal cord injury: a preliminary investigation","volume":"27","author":"Bottorff","year":"2024","journal-title":"Neuromodulation: Technology at the Neural Interface"},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0920","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/nau.70032","article-title":"A randomized controlled trial of percutaneous tibial nerve stimulation in the treatment of female sexual dysfunction","volume":"44","author":"Huang","year":"2025","journal-title":"Neurourol. Urodyn."},{"issue":"12","key":"10.1016\/j.prdoa.2026.100452_b0925","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/mdc3.70198","article-title":"A Pragmatic approach to sexual health in movement disorders","volume":"12","author":"Chen","year":"2025","journal-title":"Movement Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0930","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/sxmrev\/qeaf030","article-title":"Sexual and reproductive health in neurological disorders: recommendations from the fifth international consultation on sexual medicine (ICSM 2024)","volume":"13","author":"Elliott","year":"2025","journal-title":"Sex. Med. Rev."},{"key":"10.1016\/j.prdoa.2026.100452_b0935","doi-asserted-by":"crossref","unstructured":"Urso D, Leta V, Rukavina K. Chapter Five - Management strategies of sexual dysfunctions in Parkinson\u2019s disease. In: Chaudhuri KR, Falup-Pecurariu C, Parry M, editors International Review of Neurobiology. Academic Press;p97\u2013116. https:\/\/doi.org\/10.1016\/bs.irn.2021.12.004.","DOI":"10.1016\/bs.irn.2021.12.004"},{"issue":"3","key":"10.1016\/j.prdoa.2026.100452_b0940","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10072-022-06572-0","article-title":"Sexual dysfunction therapeutic approaches in patients with multiple sclerosis: a systematic review","volume":"44","author":"Giannopapas","year":"2023","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100452_b0945","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1877718X251394341","article-title":"Evaluation and management of male sexual dysfunction in Parkinson\u2019s disease: a clinical road map","volume":"16","author":"Rafetto","year":"2026","journal-title":"J. Parkinson\u2019s Disease"},{"key":"10.1016\/j.prdoa.2026.100452_b0950","doi-asserted-by":"crossref","unstructured":"Subramanian I, Brindle S, Perepezko K, Chaudhuri KR. Chapter Eight - Wellness, sexual health, and nonmotor Parkinson\u2019s. In: Chaudhuri KR, Falup-Pecurariu C, Parry M, editors International Review of Neurobiology. Academic Press;p171\u2013184. https:\/\/doi.org\/10.1016\/bs.irn.2021.12.006.","DOI":"10.1016\/bs.irn.2021.12.006"},{"issue":"7","key":"10.1016\/j.prdoa.2026.100452_b0955","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-1331.2004.00820.x","article-title":"Pergolide mesylate can improve sexual dysfunction in patients with Parkinson\u2019s disease: the results of an open, prospective, 6\u2010month follow\u2010up","volume":"11","author":"Pohanka","year":"2004","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.prdoa.2026.100452_b0960","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.parkreldis.2005.03.004","article-title":"The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson\u2019s disease induced by pergolide: evidence from the results of an open, prospective, one-year trial","volume":"11","author":"Pohanka","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100452_b0965","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0302-2838(02)00054-4","article-title":"Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson\u2019s disease","volume":"41","author":"Raffaele","year":"2002","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.prdoa.2026.100452_b0970","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/mdc3.12997","article-title":"Sex Disparities in autonomic symptom treatment in Parkinson\u2019s disease","volume":"7","author":"Miller-Patterson","year":"2020","journal-title":"Move. Disord. Clin. Pract."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112526000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112526000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:17:25Z","timestamp":1783930645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112526000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":194,"alternative-id":["S2590112526000320"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2026.100452","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexual dysfunction in movement disorders: prevalence, clinical features, associated factors and management","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2026.100452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100452"}}